Aspirin, steroidal and non-steroidal anti-inflammatory drugs for the treatment of Alzheimer's disease-Reference-Cited by-同舟云学术

Aspirin, steroidal and non-steroidal anti-inflammatory drugs for the treatment of Alzheimer's disease

Published:2012-02-15 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Jaturapatporn Darin¹,Isaac Mokhtar Gad El Kareem Nasr²,McCleery Jenny³,Tabet Naji⁴

Affiliation:

1. Mahidol University, Bangkok and Baycrest Centre for Geriatric Care, University of Toronto; Department of Family Medicine, Ramathibodi Hospital; Toronto Canada

2. Sussex Partnership NHS Foundation Trust; Old Age Psychiatry; Master's House Compton Place Road Eastbourne East Sussex UK BN20 8BJ

3. University of Oxford; Cochrane Dementia and Cognitive Improvement Group; John Radcliffe Hospital Level 4, Main Hospital, Room 4401c Oxford Oxfordshire UK OX39DU

4. Brighton and Sussex Medical School & Cognitive Treatment and Research Unit, Sussex Partnership NHS Foundation Trust; Institute of Postgraduate Medicine; Falmer Brighton UK BN1 9PH

Publisher

Wiley

Subject

Pharmacology (medical)

Reference165 articles.

1. A randomized controlled trial of prednisone in Alzheimer's disease. Alzheimer's Disease Cooperative Study;Aisen;Neurology,2000

2. Randomized pilot study of nimesulide treatment in Alzheimer's disease;Aisen;Neurology,2002

3. Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial;Aisen;JAMA,2003

4. Aspirin in Alzheimer's disease (AD2000): a randomised open-label trial;Bentham;Lancet Neurology,2008

5. No effect of one-year treatment with indomethacin on Alzheimer's disease progression: a randomized controlled trial;Jong;PLoS ONE,2008

Cited by 229 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mesenchymal stem cell therapy for Alzheimer’s disease: A novel therapeutic approach for neurodegenerative diseases;Neuroscience;2024-09

2. Curcumin as a potential therapeutic agent for treating neurodegenerative diseases;Neurochemistry International;2024-09

3. A review of the roles of pathogens in Alzheimer’s disease;Frontiers in Neuroscience;2024-08-19

4. Differential effect of an evolving amyloid and tau pathology on brain phospholipids and bioactive lipid mediators in rat models of Alzheimer-like pathology;Journal of Neuroinflammation;2024-07-30

5. Alzheimer’s disease and its treatment–yesterday, today, and tomorrow;Frontiers in Pharmacology;2024-05-24